Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Epigenetic Silencing of BIM Mediates Chemotherapy Resistance of Patients with Burkitt Lymphoma That Can Be Overcome by Therapeutic Reactivation of BIM in Mouse and Human Lymphoma Models

Jose A. Richter, MSc, Antonio Rullan, Elena Beltran, MSc, Xabier Agirre, PhD, M.a José Calasanz, PhD, Jose Roman-Gomez, MD, Carlos Panizo, MD, Jesus M Hernandez, MD, PhD, Felipe Prosper, MD, Vicente Fresquet, PhD, Jose A. Martinez-Climent, MD, PhD

Blood (2008) 112 (11): 607.

https://doi.org/10.1182/blood.V112.11.607.607

Published: 2008

Journal Articles

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

Blood (2007) 110 (11): 3169.

https://doi.org/10.1182/blood.V110.11.3169.3169

Published: 2007

Journal Articles

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

Blood (2006) 108 (11): 103.

https://doi.org/10.1182/blood.V108.11.103.103

Published: 2006

Journal Articles

An International Multi-Center Microarray Study for the Molecular Classification of Leukemia Identifies Novel Sub-Groupings in MDS Overlapping with AML.

Ken I. Mills, PhD, Torsten Haferlach, MD, Jesus M. Hernandez, MD, Wolf-Karsten Hofmann, MD, Alexander Kohlmann, PhD, Mickey Williams, PhD, Lothar Wieczorek

Blood (2006) 108 (11): 852.

https://doi.org/10.1182/blood.V108.11.852.852

Published: 2006

Journal Articles

GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

Idoya Lahortiga, PhD, Iria Vazquez, BSc, Nerea Marcotegui, BSc, Eva Bandres, PhD, Raquel Malumbres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Jose Cervera, MD, PhD, Jesus M. Hernandez, MD, PhD, Jesus Garcia-Foncillas, MD, PhD, Maria T. Ardanaz, MD, Filomena Floristan, MD, Maria J. Calasanz, PhD, Maria D. Odero, MD, PhD

Blood (2005) 106 (11): 2378.

https://doi.org/10.1182/blood.V106.11.2378.2378

Published: 2005

Journal Articles

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Torsten Haferlach, MD, Alexander Kohlmann, PhD, Guiseppe Basso, PhD, Marie-Christine Bene, PhD, James R. Downing, PhD, Jesus M. Hernandez, MD, Wolf-Karsten Hofmann, MD, Thomas J. Kipps, PhD, Truus te Kronnie, PhD, Wei-Min Liu, Sunhee Ro, Elisabeth MacIntyre, PhD, Ken I. Mills, PhD, Claude Preudhomme, PhD, Laura Z. Rassenti, PhD, John de Vos, PhD, Mickey Williams, PhD, Lothar Wieczorek, Robin Foa, PhD

Blood (2005) 106 (11): 757.

https://doi.org/10.1182/blood.V106.11.757.757

Published: 2005

Journal Articles

Gene Expression Profiling of B-Lymphocyte and Plasma Cell Populations from Waldenström’s Macroglobulinemia. Comparison with Expression Patterns of the Same Cell-Counterparts from Other B-Cell Neoplasms.

Norma C. Gutierrez, MD, PhD, Enrique M. Ocio, MD, PhD, Patricia Maiso, BSc, Encarna Ferminan, PhD, Manuel Delgado, BSc, Ricardo Lopez-Perez, PhD, Maria L. Sanchez, BSc, Maria J. Arcos, MD, Maria J. Moro, MD, Jose M. Hernandez, MD, Alberto Orfao, MD, PhD, Ramon Garcia-Sanz, MD, PhD, Jesus M. Hernandez, MD, PhD, Jesus F. San Miguel, MD, PhD

Blood (2005) 106 (11): 503.

https://doi.org/10.1182/blood.V106.11.503.503

Published: 2005

Journal Articles

Symptomatic and Indolent Waldenström’s Macroglobulinemia Display Different Biological and Cytogenetic but Not Immunophenotypic Characteristics.

Enrique M. Ocio, MD, Gema Mateo, MD PhD, Belen Vidriales, MD PhD, Consuelo Lopez-Berges, MD PhD, Norma C. Gutierrez, MD PhD, Jesus M. Hernandez, MD PhD, Fermin M. Sanchez-Guijo, MD PhD, Maria J. Moro, MD, Jose Hernandez, MD, Javier Fernandez-Calvo, MD, Javier Garcia-Frade, MD PhD, Alberto Orfao, MD PhD, J.F. San Miguel, MD PhD

Blood (2004) 104 (11): 3654.

https://doi.org/10.1182/blood.V104.11.3654.3654

Published: 2004

Journal Articles

Comparisson of Molecular Mechanisms Altered by Treatment with Different Drugs ( Doxorubicin, Melphalan, Bortezomib, Aplidin and Arsenic Trioxide ) in Multiple Myeloma Patients Using Oligonucleotide Microarrays.

Patricia Maiso, BSC, Norma C. Gutierrez, MD, PhD, Ricardo Lopez-Perez, PhD, Gema Mateo, PhD, Isabel M. Isidro, BSC, Encarna Ferminan, PhD, Xonia Carvajal-Vergara, BSC, Juan C. Montero, PhD, Jesus M. Hernandez, MD, PhD, Atanasio Pandiella, MD, PhD, Jesus F. San Miguel, MD, PhD

Blood (2004) 104 (11): 2457.

https://doi.org/10.1182/blood.V104.11.2457.2457

Published: 2004

Journal Articles

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Blood (2004) 104 (11): 2019.

https://doi.org/10.1182/blood.V104.11.2019.2019

Published: 2004

NARROW

Epigenetic Silencing of BIM Mediates Chemotherapy Resistance of Patients with Burkitt Lymphoma That Can Be Overcome by Therapeutic Reactivation of BIM in Mouse and Human Lymphoma Models

An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy.

An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy.

An International Multi-Center Microarray Study for the Molecular Classification of Leukemia Identifies Novel Sub-Groupings in MDS Overlapping with AML.

GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling.

Gene Expression Profiling of B-Lymphocyte and Plasma Cell Populations from Waldenström’s Macroglobulinemia. Comparison with Expression Patterns of the Same Cell-Counterparts from Other B-Cell Neoplasms.

Symptomatic and Indolent Waldenström’s Macroglobulinemia Display Different Biological and Cytogenetic but Not Immunophenotypic Characteristics.

Comparisson of Molecular Mechanisms Altered by Treatment with Different Drugs ( Doxorubicin, Melphalan, Bortezomib, Aplidin and Arsenic Trioxide ) in Multiple Myeloma Patients Using Oligonucleotide Microarrays.

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only